AMANDA LEONELLO: Open Payments
NPI 1518548239 · AUBURN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 36 payments from 14 companies in 2025. Trend: 2023 $677 · 2024 $916 · 2025 $742
Food & beverage: $704Education: $38
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $216 |
| AstraZeneca Pharmaceuticals LP | 4 | $168 |
| Calliditas Therapeutics US Inc. | 2 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Travere Therapeutics, Inc. | 10 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Lilly USA, LLC | 1 | $34 |
| Laborie Medical Technologies Corp. | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
| OPKO Pharmaceuticals, LLC | 1 | $22 |
Products named: Kerendia, LOKELMA, JARDIANCE, TARPEYO, Fabhalta, Optilume BPH Drug Coated Balloon Catheter, PURIFIED CORTROPHIN GEL, RAYALDEE.
Industry payments across NY — which companies pay providers there.
